[go: up one dir, main page]

AU7981791A - Orally administrable gallium compositions and methods of treatment therewith - Google Patents

Orally administrable gallium compositions and methods of treatment therewith

Info

Publication number
AU7981791A
AU7981791A AU79817/91A AU7981791A AU7981791A AU 7981791 A AU7981791 A AU 7981791A AU 79817/91 A AU79817/91 A AU 79817/91A AU 7981791 A AU7981791 A AU 7981791A AU 7981791 A AU7981791 A AU 7981791A
Authority
AU
Australia
Prior art keywords
methods
orally administrable
treatment therewith
gallium compositions
gallium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79817/91A
Inventor
Mahendra Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUJISAWA Inc
Original Assignee
FUJISAWA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUJISAWA Inc filed Critical FUJISAWA Inc
Publication of AU7981791A publication Critical patent/AU7981791A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545Heterocyclic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU79817/91A 1990-05-24 1991-05-22 Orally administrable gallium compositions and methods of treatment therewith Abandoned AU7981791A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52856390A 1990-05-24 1990-05-24
US528563 1990-05-24

Publications (1)

Publication Number Publication Date
AU7981791A true AU7981791A (en) 1991-12-10

Family

ID=24106201

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79817/91A Abandoned AU7981791A (en) 1990-05-24 1991-05-22 Orally administrable gallium compositions and methods of treatment therewith

Country Status (2)

Country Link
AU (1) AU7981791A (en)
WO (1) WO1991017751A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
EP0612246B1 (en) * 1991-11-12 2000-08-30 BERNSTEIN, Lawrence Richard Dr. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
US5747482A (en) * 1996-07-30 1998-05-05 Bernstein; Lawrence R. Methods and compositions to inhibit keratinocyte proliferation
EP1706148A2 (en) * 2004-01-14 2006-10-04 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
US20070098815A1 (en) 2005-10-27 2007-05-03 Bernstein Lawrence R Orally Administrable Gallium Compositions and Methods of Use
EA200801261A1 (en) 2005-11-04 2008-08-29 Джента Инкорпорейтед PHARMACEUTICAL COMPOSITIONS BASED ON GALLIUM AND METHODS
EP2099464B1 (en) 2006-11-09 2016-05-25 BERNSTEIN, Lawrence Richard Local administration of gallium compositions to treat pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591506A (en) * 1976-10-14 1986-05-27 Bonadio George A H Oral ingestion of indium
US4448763A (en) * 1980-11-10 1984-05-15 The University Of Kentucky Research Foundation Alteration of gallium biodistribution using indium complexes for enhanced early imaging
FR2500303A1 (en) * 1981-02-20 1982-08-27 Meram Lab GALLIUM CHLORIDE, A NEW ANTI-CANCER DRUG
EP0109564B1 (en) * 1982-10-22 1988-04-27 Sloan-Kettering Institute For Cancer Research The use of gallium salts for the manufacture of pharmaceutical compositions for the treatment of disorders of calcium homeostasis
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
US4704277A (en) * 1985-04-30 1987-11-03 Sloan-Kettering Institute For Cancer Research Methods of treating bone disorders

Also Published As

Publication number Publication date
WO1991017751A1 (en) 1991-11-28

Similar Documents

Publication Publication Date Title
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU7211787A (en) Intraocular dosage compositions and method of use
AU573133B2 (en) Synergistic biocide of 5-chloro-2methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one
AU8117591A (en) Treatment of water
AU7445594A (en) Orally administrable opiod formulations having extended duration of effect
EP0581581A3 (en) Bioadhesive treatment compositions and methods of use
AU4205789A (en) Method and composition for the treatment and prevention of viral infections
AU3691793A (en) Gas well treatment compositions and methods
ZA941860B (en) Halogen compositions for water treatment and method of preparation thereof
AU5590596A (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
AU3519893A (en) Antitumor compositions and methods of treatment
AU2260088A (en) Methods and compositions for the treatment of lung conditions
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU8044491A (en) Antitumor compositions and methods of treatment
SG44524A1 (en) Methods and compositions of treating malaria and other diseases
AU2114792A (en) Win 49596-finasteride method of use and compositions
AU8192691A (en) Method of treatment and compositions therefore
AU7997491A (en) Extended-release plaque preventing and dissolving compositions and their method of use
AU7981791A (en) Orally administrable gallium compositions and methods of treatment therewith
AU8427091A (en) Gamma-carboxylase and methods of use
AU3074592A (en) Compositions for delayed treatment of ischemia-related neuronal damage
AU7770991A (en) Method and composition for the treatment of cancer
AU7155491A (en) Compositions and methods for preventing and treating rotaviral infections
AU5293293A (en) Methods and compositions for treatment of allergic disease
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes